New Haven

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Hypertrophic cardiomyopathy2 trials
• Glioblastoma1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed3 trials

Lead sponsor

• Bristol-Myers Squibb3 trials

Closed trials

• Completed

  A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy

  NCT04349072· Phase 3· Bristol-Myers Squibb· Source

• Completed

  Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER

  NCT03496168· Phase 2· Bristol-Myers Squibb· Source

• Completed

  A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

  NCT02017717· Phase 3· Bristol-Myers Squibb· Source